(Q37925098)

25 August 2017

1 reference

title

Molecular pathology of tumor-initiating cells: lessons from Philadelphia chromosome-positive leukemia (English)

1 reference

25 August 2017

0 references

1 reference

4

Atsushi Hirao

1 reference

25 August 2017

Kazuhito Naka

1

1 reference

25 August 2017

Takayuki Hoshii

series ordinal

2

1 reference

25 August 2017

Yuko Tadokoro

series ordinal

3

1 reference

25 August 2017

publication date

22 June 2011

1 reference

25 August 2017

published in

Pathology International

1 reference

25 August 2017

volume

61

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

501-508

1 reference

"Stemness": transcriptional profiling of embryonic and adult stem cells

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

A stem cell molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Epigenetic signatures of stem-cell identity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Genetic variegation of clonal architecture and propagating cells in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Molecular biology of bcr-abl1-positive chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Maintenance of genomic integrity in hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Insights into the stem cells of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

PML targeting eradicates quiescent leukaemia-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Hematology: curing CML with imatinib--a dream come true?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Dynamics of chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Patching the gaps in Hedgehog signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

5-Lipoxygenase: regulation of expression and enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Lipid signalling in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

IFNalpha activates dormant haematopoietic stem cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Interferon in chronic myeloid leukaemia: past and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

FOXO transcription factors at the interface between longevity and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Foxo3a is essential for maintenance of the hematopoietic stem cell pool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Imaging hematopoietic precursor division in real time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Regulation of myeloid leukaemia by the cell-fate determinant Musashi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2011.02688.X

10.1111/J.1440-1827.2011.02688.X

21 January 2018

Identifiers

DOI

1 reference

release_g7y32spq6vgofo5bmrxzx43c6u

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g7y32spq6vgofo5bmrxzx43c6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference